Salbutamol Completed Phase 4 Trials for Pompe's Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02405598Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease